Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06513832 · ClinicalTrials.gov registry record · NA
Asthma Navigator Intervention to Improve Health Equity in Children
A NA study of Asthma in Children, sponsored by Emory University.
- Recruiting
- Registry status
- NA
- Development phase
- 75
- Enrollment target
- 1
- Study location
NCT06513832: Recruiting NA study of Asthma in Children, sponsored by Emory University.
NCT06513832 is a NA study of Asthma in Children that is actively recruiting participants, run by Emory University. The registered enrollment target is 75 participants, below the 203-participant average among 44 other Asthma in Children trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06513832, a NA study of Asthma in Children, is actively recruiting participants, sponsored by Emory University.
- RECRUITING
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to improve health equity in children aged 5-16.9 years admitted to the PICU for asthma. The objectives are: * To identify the factors related to differential experiences of asthma self-management * To pilot the effectiveness of an individualized asthma navigator intervention at PICU discharge.
Primary Outcome
The occurrence of unscheduled healthcare utilization and the date and time of occurrence will be assessed through weekly screenings of each child's EMR at Children's (Epic system).
Conditions Studied
Interventions
- BEHAVIORAL The asthma navigator
Study Locations (1)
Georgia
- Children's Healthcare of Atlanta - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2025-01-17 |
| Est. Completion | 2026-08 |
| Phase | NA |
What NCT06513832 shows while recruiting
NCT06513832 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 203-participant average among 44 other Asthma in Children trials with a reported enrollment target (63% lower).
The record links to 1 condition, with Asthma in Children appearing as the primary indexed condition, and to 1 intervention - of which The asthma navigator is the first listed.
NCT06513832 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT06513832 about?
NCT06513832 is a clinical study titled "Asthma Navigator Intervention to Improve Health Equity in Children". The goal of this study is to improve health equity in children aged 5-16.9 years admitted to the PICU for asthma. The objectives are: * To identify the factors related to differential experiences of asthma self-management * To pilot the effectiveness of an individualized asthma navigator interventi...
What is the current status of trial NCT06513832?
This trial is currently recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2025-01-17. Estimated completion is 2026-08.
What conditions does trial NCT06513832 study?
This clinical trial studies the following conditions: Asthma in Children.
What interventions are being tested in trial NCT06513832?
The interventions under investigation include: The asthma navigator (BEHAVIORAL).
Who is sponsoring clinical trial NCT06513832?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06513832 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma in Children
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06513832's enrollment target sits among peer trials
75 27th of 44 higher than 18 of 44 other Asthma in Children trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Asthma in Children trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Action Towards Health Equity and Improved Air Quality in the Duwamish Valley: A Multilevel Asthma Intervention
RECRUITING · NA
-
SMART Implementation-Effectiveness Trial 1
RECRUITING · NA
-
Mechanistic Study of Inspiratory Training in Childhood Asthma (MICA)
RECRUITING · NA
-
A Culturally Tailored Scalable Asthma Intervention for Hispanic Children (Asthma Guardian)
RECRUITING · NA
-
Impact of Sleep Duration on Immune Balance in Urban Children With Asthma
RECRUITING · NA
-
Reducing Asthma Attacks in Disadvantaged School Children With Asthma
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI